RESUMO
The genome sequence of human herpesvirus 6A (HHV-6A) strain AJ was determined in a comparison of target enrichment and long-range PCR using next-generation sequencing methodologies. The analyses show 85 predicted open reading frames (ORFs), conservation with sequenced HHV-6A reference strain U1102, and closest identity to the recently determined GS strain, despite different geographic origins (United States and Gambia).
RESUMO
Human herpesvirus-6A (HHV-6A) is rarer than HHV-6B in many infant populations. However, they are similarly prevalent as germline, chromosomally integrated genomes (ciHHV-6A/B). This integrated form affects 0.1-1â% of the human population, where potentially virus gene expression could be in every cell, although virus relationships and health effects are not clear. In a Czech/German patient cohort ciHHV-6A was more common and diverse than ciHHV-6B. Quantitative PCR, nucleotide sequencing and telomeric integration site amplification characterized ciHHV-6 in 44 German myocarditis/cardiomyopathy and Czech malignancy/inflammatory disease (MI) patients plus donors. Comparisons were made to sequences from global virus reference strains, and blood DNA from childhood-infections from Zambia (HHV-6A mainly) and Japan (HHV-6B). The MI cohort were 86â% (18/21) ciHHV-6A, the cardiac cohort 65â% (13/20) ciHHV-6B, suggesting different disease links. Reactivation was supported by findings of 1) recombination between ciHHV-6A and HHV-6B genes in 20â% (4/21) of the MI cohort; 2) expression in a patient subset, of early/late transcripts from the inflammatory mediator genes chemokine receptor U51 and chemokine U83, both identical to ciHHV-6A DNA sequences; and 3) superinfection shown by deep sequencing identifying minor virus-variants only in ciHHV-6A, which expressed transcripts, indicating virus infection reactivates latent ciHHV-6A. Half the MI cohort had more than two copies per cell, median 5.2, indicative of reactivation. Remarkably, the integrated genomes encoded the secreted-active form of virus chemokines, rare in virus from childhood-infections. This shows integrated virus genomes can contribute new human genes with links to inflammatory pathology and supports ciHHV-6A reactivation as a source for emergent infection.
Assuntos
Cromossomos Humanos/virologia , Células Germinativas/virologia , Herpesvirus Humano 6/genética , Infecções por Roseolovirus/virologia , Estudos de Coortes , Citocinas/análise , República Tcheca , Alemanha , Humanos , Lactente , Dados de Sequência Molecular , Análise de Sequência de DNA , Proteínas Virais/análise , Ativação ViralRESUMO
Human monocytes expressing CCR2 with CD14 and CD16 can mediate antigen presentation, and promote inflammation, brain infiltration and immunosenescence. Recently identified roles are in human immunodeficiency virus infection, tuberculosis and parasitic disease. Human herpesvirus 6B (HHV-6B) encodes a chemokine, U83B, which is monospecific for CCR2, and is distinct from the related HHV-6A U83A, which activates CCR1, CCR4, CCR5, CCR6 and CCR8 on immune effector cells and dendritic cells. These differences could alter leukocyte-subset recruitment for latent/lytic replication and associated neuroinflammatory pathology. Therefore, cellular interactions between U83A and U83B could help dictate potential tropism differences between these viruses. U83A specificity is maintained in the 38-residue N-terminal spliced-truncated form. Here, we sought to determine the basis for the chemokine receptor specificity differences and identify possible applications. To do this we first analysed variation in a natural host population in sub-Saharan Africa where both viruses are equally prevalent and compared these to global strains. Analyses of U83 N-terminal variation in 112 HHV-6A and HHV-6B infections identified 6/38 U83A or U83B-specific residues. We also identified a unique single U83A-specific substitution in one U83B sequence, 'U83BA'. Next, the variation effects were tested by deriving N-terminal (NT) 17-mer peptides and assaying activation of ex vivo human leukocytes, the natural host and cellular target. Chemotaxis of CCR2+ leukocytes was potently induced by U83B-NT, but not U83BA-NT or U83A-NT. Analyses of the U83B-NT activated population identified migrated CCR2+, but not CCR5+, leukocytes. The U83BA-NT asparagine-lysine14 substitution disrupted activity, thus defining CCR2 specificity and acting as a main determinant for HHV-6A/B differences in cellular interactions. A flow-cytometry-based shape-change assay was designed, and used to provide further evidence that U83B-NT could activate CCR2+CD14+CD16+ monocytes. This defines a potential antiviral target for HHV-6A/B disease and novel peptide immunomodulator for proinflammatory monocytes.
Assuntos
Quimiocinas/imunologia , Herpesvirus Humano 6/imunologia , Monócitos/imunologia , Peptídeos/imunologia , Receptores CCR2/metabolismo , Receptores de Quimiocinas/metabolismo , Proteínas Virais/imunologia , Quimiotaxia de Leucócito , Citometria de Fluxo/métodos , Humanos , Inflamação , Receptores de Lipopolissacarídeos/genética , Receptores de Lipopolissacarídeos/metabolismo , Monócitos/efeitos dos fármacos , Monócitos/metabolismo , Receptores CCR2/genética , Receptores de IgG/genética , Receptores de IgG/metabolismoRESUMO
BACKGROUND: Human immunodeficiency virus (HIV) and human cytomegalovirus (HCMV) coinfections have been shown to increase infant morbidity, mortality, and AIDS progression. In HIV-endemic regions, maternal HIV-exposed but HIV-uninfected infants, which is the majority of children affected by HIV, also show poor growth and increased morbidity. Although nutrition has been examined, the effects of HCMV infection have not been evaluated. We studied the effects of HCMV infection on the growth, development, and health of maternally HIV-exposed and unexposed infants in Zambia. METHODS: Infants were examined in a cohort recruited to a trial of micronutrient-fortified complementary foods. HIV-infected mothers and infants had received perinatal antiretroviral therapy to prevent mother-to-child HIV transmission. Growth, development, and morbidity were analyzed by linear regression analyses in relation to maternal HIV exposure and HCMV infection, as screened by sera DNA for viremia at 6 months of age and by antibody for infection at 18 months. RESULTS: All HCMV-seropositive infants had decreased length-for-age by 18 months compared with seronegative infants (standard deviation [z]-score difference: -0.44 [95% confidence interval {CI}, -.72 to -.17]; P = .002). In HIV-exposed infants, those who were HCMV positive compared with those who were negative, also had reduced head size (mean z-score difference: -0.72 [95% CI, -1.23 to -.22]; P = .01) and lower psychomotor development (Bayley test score difference: -4.1 [95% CI, -7.8 to -.5]; P = .03). HIV-exposed, HCMV-viremic infants were more commonly referred for hospital treatment than HCMV-negative infants. The effects of HCMV were unaffected by micronutrient fortification. CONCLUSION: HCMV affects child growth, development, and morbidity of African infants, particularly in those maternally exposed to HIV. HCMV is therefore a risk factor for child health in this region.
Assuntos
Desenvolvimento Infantil , Infecções por Citomegalovirus/patologia , Infecções por Citomegalovirus/transmissão , Infecções por HIV/complicações , Infecções por HIV/transmissão , Anticorpos Antivirais , Infecções por Citomegalovirus/epidemiologia , Feminino , Infecções por HIV/epidemiologia , Humanos , Recém-Nascido , Transmissão Vertical de Doenças Infecciosas , Gravidez , Complicações Infecciosas na Gravidez , Zâmbia/epidemiologiaRESUMO
Human cytomegalovirus, HCMV, was analysed using real-time quantitative PCR in symptomatic or asymptomatic pediatric cohorts from HIV-1 infected, exposed (HIV-1+ mothers), or uninfected groups in Zambia, an HIV-1/AIDS endemic region of Africa. HCMV infections were identified in 94% samples from HIV-1+ respiratory pediatric mortalities, 50% with high DNA loads of 10(3)-10(8) copies/10(6) cells. In comparison, HCMV viremia with high DNA loads, indicative of acute infections, were in 10% hospitalised febrile infants, with 50% HIV-1+. Whereas high sera loads were in 1% of asymptomatic infants, with 2% HIV-1+, and higher levels in both HIV-1 infected or exposed, but negative infants. All 8 linked-hypervariable glycoprotein gN-gO genotypes were shown, including identification of a new gN4d group with gO5 linkage (previously only Merlin reference strain), and samples with multiple infections. Overall, this shows global genotypes in Africa (unlike some herpesviruses) and acute pediatric HCMV infections in both HIV-1+ plus exposed, but uninfected infants, an emerging group.
Assuntos
Infecções por Citomegalovirus/epidemiologia , Infecções por Citomegalovirus/virologia , Citomegalovirus/isolamento & purificação , Infecções por HIV/complicações , Carga Viral , Adolescente , Criança , Pré-Escolar , Citomegalovirus/classificação , DNA Viral/genética , Genótipo , Humanos , Lactente , Zâmbia/epidemiologiaRESUMO
Kaposi's sarcoma-associated herpesvirus (KSHV or HHV-8) has been associated with several neoplasias, including childhood endemic Kaposi's sarcoma (KS). It is possible that strain genotypes could contribute to the differences in regional presentation (mainly sub-Saharan Africa), childhood infection, lack of male sex bias, distinct disseminated forms and rapid fatality observed for childhood endemic KS. Early studies, at the advent of the HIV/AIDS epidemic, identified only the K1-A5 genotype in childhood KS biopsies as well as blood of a few HIV positive and negative febrile infants in Zambia, a highly endemic region. This current enlarged study analyses blood infections of 200 hospitalized infants (6-34 months age) with symptoms of fever as well as upper respiratory tract infection, diarrhoea, rash or rhinitis. KSHV and HIV viraemia and were prevalent in this group, 22% and 39%, respectively. Multiple markers at both variable ends of the genome (K1, K12, and K14.1/K15) were examined, showing diverse previously adult-linked genotypes (K1 A2, A5, B, C3, D, with K12 B1 and B2 plus K14.1/K15 P or M) detected in both HIV positive and negative infants, demonstrating little restriction on KSHV genotypes for infant/childhood transmission in a childhood endemic KS endemic region. This supports the interpretation that the acquisition of childhood KSHV infections and subsequent development of KS are due to additional co-factors.
Assuntos
Doenças Endêmicas/prevenção & controle , Infecções por HIV , Herpesvirus Humano 8/genética , Sarcoma de Kaposi/epidemiologia , Sequência de Aminoácidos , Pré-Escolar , Diarreia/patologia , Exantema/patologia , Febre de Causa Desconhecida/patologia , Febre de Causa Desconhecida/virologia , Genes Virais , Humanos , Lactente , Dados de Sequência Molecular , Rinite/patologia , Alinhamento de Sequência , Proteínas Virais/genética , Viremia , Zâmbia/epidemiologiaRESUMO
Previously, we identified the glycoprotein gO gene, UL74, as a hypervariable locus in the human cytomegalovirus (HCMV) genome [Virology 293 (2002) 281]. Here, we analyze gO from 50 isolates from congenitally infected newborns, transplant recipients, and HIV/AIDS patients from Italy, Australia, and UK. These are compared to four gO groups described from USA transplantation patients [J. Virol. 76 (2002) 10841]. Phylogenetic analyses identified seven genotypes. Divergence between genotypes was up to 55% and within 3%. Discrete linkage was shown between seven hypervariable gO and gN genotypes, but not with gB. This suggests interactions, while gN and gO are known to form complexes with distinct conserved glycoproteins gM, gH/gL, respectively, both are involved in fusogenic entry and exit. Codon-based maximum likelihood models showed evidence for sites of positive selection. Further analyses of disease relationships should take into account these newly defined gO/gN groups.
Assuntos
Citomegalovirus/genética , Glicoproteínas de Membrana/genética , Proteínas do Envelope Viral/genética , Sequência de Aminoácidos , Citomegalovirus/química , Citomegalovirus/isolamento & purificação , Ligação Genética , Variação Genética , Genótipo , Humanos , Dados de Sequência Molecular , Filogenia , Seleção Genética , Alinhamento de SequênciaRESUMO
The human herpesvirus 6 (HHV-6) U51 gene defines a new family of betaherpesvirus-specific genes encoding multiple transmembrane glycoproteins with similarity to G protein-coupled receptors, in particular, human chemokine receptors. These are distinct from the HHV-6 U12 and HCMV US28 family. In vitro transcription and translation as well as transient cellular expression of U51 showed properties of a multiple transmembrane protein with a 30-kDa monomer as well as high m.w. aggregates or oligomers. Transient cellularly expressed U51 also appeared to form dimeric intermediates. Despite having only limited sequence similarity to chemokine receptors, U51 stably expressed in cell lines showed specific binding of the CC chemokine RANTES and competitive binding with other beta chemokines, such as eotaxin; monocyte chemoattractant protein 1, 3, and 4; as well as the HHV-8 chemokine vMIPII. In epithelial cells already secreting RANTES, U51 expression resulted in specific transcriptional down-regulation. This correlated with reduced secretion of RANTES protein into the culture supernatants. Regulation of RANTES levels may alter selective recruitment of circulating inflammatory cells that the virus can infect and thus could mediate the systemic spread of the virus from initial sites of infection in epithelia. Alternatively, chemokine regulation could modulate a protective inflammatory response to aid the spread of virus by immune evasion. Such mimicry, by viral proteins, of host receptors leading to down-regulation of chemokine expression is a novel immunomodulatory mechanism.
Assuntos
Quimiocina CCL5/metabolismo , Quimiocinas CC/metabolismo , Regulação para Baixo , Herpesvirus Humano 6/metabolismo , Receptores de Quimiocinas/fisiologia , Receptores Virais/fisiologia , Sequência de Aminoácidos , Animais , Linhagem Celular , Quimiocina CCL5/antagonistas & inibidores , Quimiocina CCL5/biossíntese , Regulação para Baixo/genética , Células Epiteliais/metabolismo , Células Epiteliais/virologia , Proteínas de Ligação ao GTP/genética , Proteínas de Ligação ao GTP/metabolismo , Genes Virais , Herpesvirus Humano 6/genética , Humanos , Células K562 , Ligantes , Dados de Sequência Molecular , Ligação Proteica/genética , Receptores de Quimiocinas/química , Receptores de Quimiocinas/genética , Receptores Virais/química , Receptores Virais/genética , Células Tumorais Cultivadas , Proteínas Virais/química , Proteínas Virais/genética , Proteínas Virais/fisiologia , Proteínas Estruturais Virais/genéticaRESUMO
There are few genes that are specific and diagnostic for human herpesvirus-6. U83 and U22 are two of them. U22 is unique, whereas U83 encodes distant similarity with some cellular chemokines. Reverse transcription-polymerase chain reaction, cDNA cloning, and sequence analyses show polyadenylated RNA transcripts corresponding to minor full-length and abundant spliced forms of U83 in human herpesvirus 6-infected cells. The splice donor and acceptor sites do not fit consensus sequences for either major GT-AG or minor AT-AC introns. However, the spliced form can also be detected in a U83 transfected cell line; thus the novel sites are used by cellular mechanisms. This intron may represent a new minor CT-AC splicing class. The novel splicing regulates gene expression by introducing a central stop codon that abrogates production of the chemokine-like molecule, resulting in an encoded truncated peptide. The use of metabolic inhibitors and an infection time course showed expression of the two RNA transcripts with immediate early kinetics. However, the full-length product accumulated later, dependent on virus DNA replication, similar to U22. Sequence analyses of 16 strains showed high variation (13%) in U83, with conservation of the novel splice sites. Representative strain variants had similar kinetics of expression and spliced products.
Assuntos
Processamento Alternativo/genética , Quimiocinas/genética , Regulação Viral da Expressão Gênica/genética , Variação Genética/genética , Herpesvirus Humano 6/genética , Proteínas Virais/genética , Regiões 3' não Traduzidas/genética , Sequência de Aminoácidos , Sequência de Bases , Sequência Consenso , DNA Complementar/metabolismo , Amplificação de Genes , Herpesvirus Humano 6/isolamento & purificação , Humanos , Células Jurkat , Dados de Sequência Molecular , RNA Viral/isolamento & purificação , Análise de Sequência de RNA , Células Tumorais CultivadasRESUMO
Human herpesvirus-6 (HHV-6), like other betaherpesviruses, shows cell fusion with wild-type strains, and this cellular spread is mediated by the glycoprotein gH/gL complex. Anti-fusion monoclonal antibodies (MAbs) specific for HHV-6 glycoprotein gH inhibit infection and prevent cellular spread by syncytia formation. Reactivity of these MAbs with gH deletion mutants suggests a conserved C-terminal fusion-associated domain. A conserved motif here has an N-glycosylation site and characteristics of a beta turn. Motif deletion abrogated MAb recognition while co-expression with glycoprotein gL restored this conformational epitope, indicating the importance of folding and not glycosylation at this site. Our previous studies showed gL binding to gH at an N-terminal domain specific for betaherpesviruses. To further examine the function of this N-terminal domain, a betaherpesvirus-specific motif was deleted. This mutant gH still bound gL, and was recognized by the anti-fusion MAbs; however, recognition was now primarily in the immature form and reduced during processing to the mature form. A model is discussed whereby gL binding gH at the N-terminal domain acts to draw together the C-terminal extracellular domain and this interaction affects a functional conformation during glycoprotein maturation.
Assuntos
Herpesvirus Humano 6/metabolismo , Fusão de Membrana/fisiologia , Proteínas do Envelope Viral/química , Proteínas do Envelope Viral/metabolismo , Animais , Anticorpos Monoclonais/imunologia , Chlorocebus aethiops , Epitopos/imunologia , Herpesvirus Humano 6/química , Herpesvirus Humano 6/genética , Herpesvirus Humano 6/patogenicidade , Humanos , Mutagênese Sítio-Dirigida , Plasmídeos , Testes de Precipitina , Conformação Proteica , Relação Estrutura-Atividade , Células Vero , Proteínas do Envelope Viral/genéticaRESUMO
PIP: This paper addresses HIV detection and its variation using degenerate polymerase chain reaction (PCR) and sequence analysis among African children. A total of 6 genomes of HIV-1 from AIDS patients, representing geographically distinct regions of Zambia and the major circulating genotypes (A, B, D, and O) were examined. Sequence multiple alignment was used to determine matches of HIV-1 and its variation, but none was suitable; hence, alignments were re-examined to design new primers. Standard PCR conditions were used with a modified cycling protocol. The new primers were tested on blood DNA from 53 HIV-negative, 60 HIV-positive febrile infants, and 9 HIV-positive children with Kaposi's sarcoma (KS). HIV status was determined in an enzyme-linked immunosorbent assay. 6 of the HIV-negative infants, 43 of those who were seropositive, and all children with KS were positive for HIV-1 proviral DNA. One PCR-positive, HIV-seronegative infant and the 9 KS samples were examined further using automated DNA sequencing and showed no evidence for contamination. Multiple alignment and phylogeny analyses using the Clustal program showed most similarity (94%) to the published adult Zambian strains. Variations in PCR detection rate in the HIV-positive infants (72%) and the KS children (100%) were brought about by confounding factors such as maternal HIV-1 infection during pregnancy without seroconversion, impaired B-cell function, and diversity of HIV-1 genotype circulating in Zambia.^ieng
Assuntos
Síndrome da Imunodeficiência Adquirida/virologia , DNA Viral/isolamento & purificação , HIV-1/isolamento & purificação , Síndrome da Imunodeficiência Adquirida/diagnóstico , Criança , Pré-Escolar , HIV-1/genética , Humanos , Dados de Sequência Molecular , Reação em Cadeia da Polimerase/métodos , Alinhamento de Sequência , Análise de Sequência de DNA/métodos , ZâmbiaRESUMO
Human herpesvirus-8 (HHV-8) DNA sequences have been identified in all forms of Kaposi's sarcoma (KS), a cancer found primarily in adult AIDS patients. We have identified HHV-8 strains in a rare human immunodeficiency virus (HIV)-negative form of KS, which is endemic in children in parts of sub-Saharan Africa. This was shown in Zambia, where we also had identified HHV-8 sequences in blood from HIV-negative febrile children without KS. In order to investigate the relationship of these Zambian strains to each other and to those from other forms of KS, we compared them to strains we have characterized from European AIDS KS (Denmark) and all published sequences from all forms of KS. Four distinct genomic regions were examined by PCR and sequencing: ORF26, ORF75, gH and K1. The results showed a distinct grouping of strains from both sets of Zambian children in all genomic regions studied, but which was most pronounced in the K1 glycoprotein gene. This gene was highly variable, encoding up to 25% amino acid sequence variation. In contrast, the Zambian groups were closely related to each other, with only 2% variation. Similar results were found in comparisons to the K1 sequences from HIV-positive febrile infants or KS children. The data raise the possibility that in areas where rare childhood endemic KS occurs, geographical variation in HHV-8 may relate to differences in virulence or transmission.
Assuntos
Infecções Oportunistas Relacionadas com a AIDS/virologia , Doenças Endêmicas , Febre/virologia , Variação Genética , Glicoproteínas/genética , Herpesvirus Humano 8/genética , Sarcoma de Kaposi/virologia , Análise de Sequência de DNA , Proteínas Virais/genética , Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Adulto , Sequência de Aminoácidos , Sequência de Bases , Sequência Conservada , DNA Viral , Genes Virais , Herpesvirus Humano 8/classificação , Humanos , Lactente , Dados de Sequência Molecular , Sarcoma de Kaposi/epidemiologia , Homologia de Sequência de Aminoácidos , Homologia de Sequência do Ácido Nucleico , ZâmbiaRESUMO
Novel herpesviruses have been described recently. These include human herpesviruses 6, 7 and 8 (HHV-6, -7, -8). HHV-6 has at least two strain groups, variants A and B. The B strains are predominant in the West and can account for over 97% of infections in infants. In contrast, the A strains are rare and the few well-characterized isolates have been from adult African AIDS patients. It is not clear whether the HHV-6 variant A strains are AIDS-related and/or whether they can also be acquired as childhood infections and may reactivate later during adulthood. What contribution geographical variation plays has yet to be assessed. HHV-8 has been associated with AIDS-related epidemic Kaposi's sarcoma (KS), but has also been identified in endemic KS. In regions of Africa where KS is endemic, the onset of AIDS has led to increased prevalence of KS. In this report, we examine in Zambia, an AIDS epidemic and KS endemic region, infection with these novel herpesviruses during infancy. In blood samples from human immunodeficiency virus-negative infants with first febrile episode, both semi-quantitative PCR and sequence analyses were used to identify HHV-8 in 8% and HHV-6 in 30%, with 44% of these variant A; in childhood endemic KS biopsies HHV-8 was detected in 100% and HHV-6 in none. The high viral-DNA loads in the infant blood samples were consistent with viraemia. This is the first demonstration that HHV-6 variant A and HHV-8 may be acquired as common childhood infections.
Assuntos
Infecções Oportunistas Relacionadas com a AIDS/virologia , Soronegatividade para HIV , Infecções por Herpesviridae/epidemiologia , Herpesvirus Humano 6/isolamento & purificação , Herpesvirus Humano 7/isolamento & purificação , Herpesvirus Humano 8/isolamento & purificação , Sarcoma de Kaposi/virologia , Infecções Oportunistas Relacionadas com a AIDS/epidemiologia , Adulto , Pré-Escolar , Feminino , Infecções por Herpesviridae/virologia , Humanos , Lactente , Masculino , Sarcoma de Kaposi/epidemiologia , Zâmbia/epidemiologiaAssuntos
Infecções por Herpesviridae/virologia , Herpesvirus Humano 8/isolamento & purificação , Anticorpos Antivirais/sangue , Criança , Infecções por Herpesviridae/epidemiologia , Infecções por Herpesviridae/transmissão , Herpesvirus Humano 4/classificação , Herpesvirus Humano 8/classificação , Herpesvirus Humano 8/imunologia , Humanos , Sarcoma de Kaposi/virologiaRESUMO
Formation of the glycoprotein gH/gL heterooligomer has important implications for understanding the pathology of human herpesvirus-6(HHV-6)-associated disease because this complex is essential for infectivity and fusogenic cell-to-cell spread. Definition of the HHV-6 gH domain involved in protein-protein interactions was addressed by targeting regions defined by conserved cysteines identified by alignment of gH amino acid sequences representative of all herpesvirus subfamilies. Studies using site-directed mutagenesis and transient cellular expression showed that the N-terminus of HHV-6 gH includes a 230-amino-acid domain required for interaction with HHV-6 gL encompassing residues conserved specifically amongst betaherpesviruses. Interestingly, the human cytomegalovirus (HCMV) homologues, UL75 (gH) or UL115 (gL), can substitute for HHV-6 glycoproteins and participate in heterologous complex formation. Furthermore, the region which governs this heterologous gL binding also maps to the N-terminal portion of HHV-6 gH. Although both proteins can functionally substitute for complex formation there are also specific differences. Surprisingly, further deletion of HHV-6 gH to 145-amino-acid-domain residues abolishes complex formation with HHV-6 gL but allows interaction with HCMV gL. This may be related to requirements in HHV-6 for homodimer formation before complex formation between gH and gL. Under nonreducing conditions HHV-6 gH and gL form multimeric complexes consistent with intra- and intermolecular dimer formation stabilised by disulphide bonds whereas for HCMV there is no evidence for dimer formation for gH and multimeric complexes have only been observed between gH and gL. In summary, both HHV-6 and HCMV glycoproteins can interact and the heterologous complex between HHV-6 gH and HCMV gL is possibly more stable. This may result in important biological consequences in vivo during cellular coinfections by facilitating spread of the viruses, with applications to altered cellular tropisms and effects on reactivation from the latently infected cell.
Assuntos
Glicoproteínas/química , Herpesvirus Humano 6/química , Proteínas do Envelope Viral/química , Sequência de Bases , Citomegalovirus/química , Efeito Citopatogênico Viral , Primers do DNA/química , Dissulfetos , Herpesvirus Humano 6/patogenicidade , Dados de Sequência Molecular , Ligação Proteica , Especificidade da Espécie , Relação Estrutura-AtividadeRESUMO
The complete DNA sequence was determined for strain U1102 of human herpesvirus-6, a CD4+ T-lymphotropic virus with disease associations in immunodeficient settings and a possible complicating factor in AIDS. The genome is 159,321 bp in size, has a base composition of 43% G + C, and contains 119 open reading frames. The overall structure is 143 kb bounded by 8 kb of direct repeats, DRL (left) and DRR (right), containing 0.35 kb of terminal and junctional arrays of human telomere-like simple repeats. Since eight open reading frames are duplicated in the repeats, six span repetitive elements and three are spliced, the genome is considered to contain 102 separate genes likely to encode protein. The genes are arranged colinearly with those in the genome of the previously sequenced betaherpesvirus, human cytomegalovirus, and has a distinct arrangement of conserved genes relative to the sequenced gammaherpesviruses, herpesvirus saimiri and Epstein-Barr virus, and the alphaherpesviruses, equine herpesvirus-1, varicella-zoster virus, and herpes simplex virus. Comparisons of predicted amino acid sequences allowed the functions of many human herpesvirus-6 encoded proteins to be assigned and showed the closest relationship in overall number and similarity to human cytomegalovirus products, with approximately 67% homologous proteins as compared to the 21% identified in all herpesviruses. The features of the conserved genes and their relative order suggested a general scheme for divergence among these herpesvirus lineages. In addition to the "core" conserved genes, the genome contains four distinct gene families which may be involved in immune evasion and persistence in immune cells: two have similarity to the "chemokine" chemotactic/proinflammatory family of cytokines, one to their peptide G-protein-coupled receptors, and a fourth to the immunoglobulin superfamily.
Assuntos
Evolução Biológica , DNA Viral/genética , Genoma Viral , Herpesvirus Humano 6/genética , Infecções Oportunistas Relacionadas com a AIDS/virologia , Composição de Bases , Sequência de Bases , Betaherpesvirinae/genética , Linhagem Celular , Mapeamento Cromossômico , Replicação do DNA/genética , DNA Viral/química , DNA Viral/metabolismo , Rearranjo Gênico , Infecções por Herpesviridae/complicações , Herpesvirus Humano 6/metabolismo , Humanos , Proteínas Imediatamente Precoces/genética , Sistema Imunitário/virologia , Família Multigênica , Ativação Transcricional , Proteínas Virais/genéticaRESUMO
Here we examine by polymerase chain reaction amplification followed by cloning and sequence analyses selected regions of the human herpesvirus 6 (HHV-6) genome which contain human telomeric repeats (TTA-GGG). We determine the relative number, arrangement and orientation of the repeats in the unit length genome, in concatemeric replicative intermediates and in heterogeneous (het) regions. We also examine distribution of the repeats in the entire genome (159 kb) and their orientation relative to DNA packaging motifs and the origin of lytic replication. In the prototype orientation the HHV-6 repeat is the related complement, TAACCC. We show that tandem arrays of this repeat are present in the right and left long direct repeats (DRL and DRR, 8 kb each) which bound the long unique sequence (UL, 143 kb). Within each DR there is a left terminal imperfect tandem array and a right terminal perfect tandem array (58 copies). In DR they are each adjacent to DNA packaging motifs, pac1 and pac2, described for herpes simplex virus and human cytomegalovirus, in the arrangement pac1-imperfect repeat-7.2 kb-perfect repeat-pac2. Five independent clones were isolated and sequence determined from junctions of concatemeric replicative intermediates which showed adjacent pac2 and pac1 motifs surrounded by telomeric repeats. Favoured cleavage sites for unit length genomes were indicated which avoided cleavage within the repeats. Analyses of the complete genome showed no tandem repeats within UL but did show a polar distribution of monomeric copies and related sequences around the origin of replication, with an effect on the overall base composition. The implications for virus replication are discussed.
Assuntos
Herpesvirus Humano 6/genética , Sequências Repetitivas de Ácido Nucleico , Telômero , Replicação Viral , Sequência de Aminoácidos , Sequência de Bases , Genoma Viral , Herpesvirus Humano 6/fisiologia , Dados de Sequência MolecularRESUMO
Previous studies have shown that monoclonal antibody (MAb) 2E4 neutralizes infectivity of human herpesvirus-6 (HHV-6) and also inhibits virus-induced T-lymphocyte syncytia formation. Here we characterize two additional MAbs, 1D3 and 5E7, which have similar properties, and identify the glycoprotein targets. The MAbs could immunoprecipitate and immunofluorescence glycoprotein from both A and B variant strain groups of HHV-6. In reactions with infected cells the MAbs immunoprecipitated a complex of glycoproteins, the "gp100" complex, composed of a major glycoprotein species of 100,000 M(r) and minor components of 80,000 M(r) and 32,000 M(r). We show that the 100,000 M(r) product and most likely the 80,000 M(r) correspond to the HHV-6 homologue of herpes simplex virus-1 (HSV-1) glycoprotein H (gH) while the 32,000 M(r) species corresponds to the glycoprotein L (gL) equivalent. All three MAbs could specifically immunoprecipitate either gH expressed on its own in fibroblasts or a complex of gH and gL co-expressed, but could not immunoprecipitate gL expressed on its own. Consistent with these results, the MAbs could recognize gH in an immunofluorescence assay but not gL. Therefore although the MAbs recognized the complex of glycoproteins, they appeared specific for gH. The HHV-6 glycoproteins were produced in a transient expression system induced by T7-vaccinia virus. Immunoprecipitations were carried out in comparisons with an "epitope-tagged" gH, a recombinant glycoprotein designed to contain at the N-terminus the linear epitope for MAb LP14, raised originally against HSV-1 glycoprotein gD. The epitope-tagged gH was also used as a positive control in determining the domain of HHV-6 gH to which MAbs 2E4, 1D3 and 5E7 were directed. Two gH deletions were constructed, one deleting sequences which may serve as a transmembrane and cytoplasmic anchor domains, the second deleting also part of the external domain. MAb LP14 could immunoprecipitate both HHV-6 gH deletions but the gp100 MAbs recognized only the full-length product or the intact external domain minus the transmembrane and cytoplasmic domains. This indicated the epitopes for these MAbs are contained in the external domain of gH, consistent with the MAbs action in neutralization of virion infectivity and inhibition of virus to cell spread by T-lymphocyte fusion.
Assuntos
Anticorpos Monoclonais/metabolismo , Glicoproteínas/metabolismo , Herpesvirus Humano 6/metabolismo , Proteínas do Envelope Viral/metabolismo , Proteínas Virais/metabolismo , Sequência de Aminoácidos , Animais , Reações Antígeno-Anticorpo , Sequência de Bases , Linhagem Celular , Primers do DNA , Eletroforese em Gel de Poliacrilamida , Epitopos/análise , Imunofluorescência , Glicoproteínas/imunologia , Glicoproteínas/isolamento & purificação , Herpesvirus Humano 6/imunologia , Humanos , Camundongos , Camundongos Endogâmicos BALB C/imunologia , Dados de Sequência Molecular , Peso Molecular , Mutagênese Sítio-Dirigida , Testes de Neutralização , Reação em Cadeia da Polimerase , Deleção de Sequência , Homologia de Sequência de Aminoácidos , Transfecção , Proteínas do Envelope Viral/imunologia , Proteínas do Envelope Viral/isolamento & purificação , Proteínas Virais/imunologia , Proteínas Virais/isolamento & purificaçãoRESUMO
In herpes simplex virus (HSV) the small secreted glycoprotein gL forms a heterodimer with the transmembrane envelope glycoprotein gH. Here we identify the human herpesvirus 6 (HHV-6) gL gene, express HHV-6 gL and gH homologues, and examine interactions between HHV-6 gH and gL. The HHV-6 gL gene encoded a glycoprotein with an amino acid sequence which showed closest similarity to the human cytomegalovirus (HCMV) gL homologue (18% identity). Products of HHV-6 gH and gL genes were characterized in an in vitro transcription-translation system and in a transient in vivo expression system. Both gH and gL were transcribed and translated in vitro to give products of apparent M(r) of 65K and 28K in SDS-PAGE, and these could be processed by addition of microsomes to 110K and 40K, respectively. To study gH/gL interactions, gH was tagged with the nine amino acid epitope for monoclonal antibody LP14 (anti-HSV-1 gD). LP14 and a human serum sample specifically immunoprecipitated gH and a stable complex of gH and gL co-expressed in an in vivo vaccinia virus-T7 system. The gH and gL produced in this in vivo expression system corresponded to the M(r)s of the fully processed glycoproteins identified in the in vitro system. The gH expressed together with gL was recognized by human sera more easily than when examined on its own in immunofluorescence assays. Dual expression of gH and gL in transfected T lymphocytes (JJhan) caused reactions with 75% of human sera tested (12 HHV-6-positive, HCMV-negative serum samples), but gL expressed alone was not recognized by these sera. The immunofluorescence studies also showed that the glycoproteins were localized in Golgi-like bodies in fibroblasts, but occurred throughout the endoplasmic reticulum in T lymphocytes, the normal cellular target for HHV-6. These results show the identification of the HHV-6 homologue to the HCMV and HSV gL genes, identification and production of HHV-6 gH and gL expressed both in vitro and in vivo, complex formation between these glycoproteins, and evidence that this complex may be localized differently in fibroblasts as compared to T lymphocytes and that it is immunogenic.